Monoclonal Antibody Therapy Against Chronic Herpes Simplex Virus 2 Infection

Condition:   Herpes Genitalis Interventions:   Biological: HDIT101;   Drug: Valaciclovir;   Biological: HDIT101 placebo;   Drug: Valaciclovir placebo Sponsor:   Heidelberg ImmunoTherapeutics GmbH Not yet recruiting

Source: ClinicalTrials.gov - November 15, 2019 Category: Research Source Type: clinical trials